T. Nishikiori, A. Fujii and T. Takita, J. Antibiot., 1987, 40, 1788;
(c) J. Seki, N. Shimada, K. Takahashi, T. Takita, T. Yakeuchi and
H. Hoshino, Antimicrob. Agents Chemother., 1989, 33, 773.
3 (a) T. Nagahata, K. Araki, K. Yamamura and K. Matsubara,
Antimicrob. Agents Chemother., 1992, 36, 2042; (b) E. Ichikawa
and K. Kato, Antimicrob. Agents Chemother., 1994, 38, 707.
4 J. Alder, M. Mitten, D. Norbeck, K. Marsh, E. R. Kern and
J. Clement, Antiviral Res., 1994, 23, 93.
5 E. V. Genovesi, L. Lamb, I. Medina, D. Taylor, M. Seifer,
S. Innaimo, R. J. Colonno and J. M. Claek, Antiviral Res., 2000,
48, 197.
6 (a) G. M. Blackburn, D. A. England and F. Kolkmann, J. Chem.
Soc., Chem. Commun., 1981, 930; (b) G. M. Blackburn, D. Brown and
S. J. Martin, J. Chem. Res., Synop., 1985, 92; (c) G. M. Blackburn,
F. Eckstein, D. E. Kent and T. D. Perree, Nucleosides Nucleotides,
1985, 4, 165; (d) G. M. Blackburn and D. E. Kent, J. Chem. Soc.,
Perkin Trans. 1, 1986, 913; (e) G. M. Blackburn, T. D. Perree,
A. Rashid, C. Bisbal and B. Levleu, Chem. Scr., 1986, 26, 21;
(f) G. M. Blackburn, D. Brown, S. J. Martin and M. J. Parratt,
J. Chem. Soc., Perkin Trans. 1, 1987, 181 for recent examples of CF2
containing nucleosides, see:; (g) Y.-Y. Yang, W.-D. Meng and
F.-L. Qimg, Org. Lett., 2004, 6, 4257; (h) Y.-Y. Yang, J. Xu,
Z.-W. You, X.-H. Xu, X.-L. Qiu and F.-L. Qing, Org. Lett., 2007,
9, 5437; (i) H. Kumamoto, K. Haraguchi, M. Ida, K. T. Nakamura,
Y. Kitagawa, T. Hamasaki, M. Baba, S. S. Matsubayashi and
H. Tanaka, Tetrahedron, 2009, 65, 7630.
Scheme 2 Synthesis of 4.
Fig. 3 ORTEP drawing of compound 4.
7 For general reviews, see: (a) A. L. J. Beckwith, Tetrahedron, 1981,
37, 3073; (b) A. Srikrishna, Curr. Sci., 1987, 56, 392;
(c) M. Ramaiah, Tetrahedron, 1987, 43, 3541; (d) P. Curran,
Synthesis, 1988, 417.
(86% yield) by oxidation with m-CPBA and subsequent syn-
elimination of the respective selenoxide. Next, 16 was transformed
into 17 (diastereomeric mixture; ca. 3 : 1) in 65% yield through the
following four steps: (1) Lemieux–Johnson oxidation in the
presence of 2,6-lutidine,16 (2) NaBH4 reduction of the resulting
aldehyde, (3) benzylation of the primary alcohol, (4) removal of the
TBS group by using Bu4NF. Next, the cyclobutylamine 19 was
synthesized through (1) Dess–Martin periodinane (DMP) oxidation
of 17, (2) oximation of the ketone, (3) LiAlH4 reduction of the
oxime.17 Although, the yield was not satisfied (32%), amine 19 was
obtained as a single stereoisomer. Finally, 19 was transformed into
the corresponding thymine nucleoside by a reported procedure18
using isocyanate 18. Debenzylation with Pd(OH)2/C gave the title
compound 4 in 56% yield. The relative stereochemistry of 4 was
assigned by NOE experiments (see ESIw) and confirmed by X-ray
crystallographic analysis (Fig. 3).
8 J. E. Baldwin, J. Chem. Soc., Chem. Commun., 1976, 734.
9 For examples, see: (a) S.-U. Park, T. R. Varick and M. Newcomb,
Tetrahedron Lett., 1990, 31, 2975; (b) K. Ogura, N. Sumitani,
A. Kayano, H. Iguchi and M. Fujita, Chem. Lett., 1992, 1487;
(c) M. E. Jung, I. D. Trifunovich and N. Lensen, Tetrahedron Lett.,
1992, 33, 6719; (d) M. E. Jung and J. Gervay, J. Am. Chem. Soc.,
1991, 113, 224; (e) M. E. Jung, R. Marquez and K. N. Houk,
Tetrahedron Lett., 1999, 40, 2661; (f) M. E. Jung, Synlett, 1999,
843; (g) D. Johnston, C. M. McCusker and D. J. Procter, Tetra-
hedron Lett., 1999, 40, 4913; (h) D. Johnston, C. M. McCusker,
K. Muir and D. J. Procter, J. Chem. Soc., Perkin Trans. 1, 2000,
681; (i) D. Johnston, N. Francon, D. J. Edmonds and
D. J. Procter, Org. Lett., 2001, 3, 2001; (j) D. J. Edmonds,
K. W. Muir and D. J. Procter, J. Org. Chem., 2003, 68, 3190;
(k) H. Y. Harb, K. D. Collins, J. V. Garcia Altur, S. Bowker,
L. Campbell and D. J. Procter, Org. Lett., 2010, 12, 5446;
(l) H. Y. Harb and D. J. Procter, Synlett, 2012, 6.
10 (a) R. M. Beesley, C. K. Ingold and J. F. Thorpe, J. Chem. Soc.
Abstr., 1915, 107, 1080; (b) C. K. Ingold, J. Chem. Soc. Abstr.,
1921, 119, 305; (c) R. F. Brown and N. M. VanGulick, J. Org.
Chem., 1956, 21, 1046; (d) P. von R. Schleyer, J. Am. Chem. Soc.,
1961, 83, 1368.
11 B. Giese, Angew. Chem., Int. Ed. Engl., 1983, 22, 753.
12 S. Baeluenga, E. Moulin, P. Lopez and N. Winssinger, Chem.–Eur. J.,
2005, 11, 4935.
13 (a) A. Otaka, J. Watanabe, A. Yukimasa, Y. Sasaki, H. Watanabe,
T. Kinoshita, S. Oishi, H. Tamamura and N. Fujii, J. Org. Chem., 2004,
69, 1634; (b) M. Schuler, F. Silva, C. Bobbio, A. Tessier and
V. Gouverneur, Angew. Chem., Int. Ed., 2008, 47, 7927; (c) Y.-K.
Chang, J. Lee, G.-S. Park, M. Lee, C. H. Park, H. K. Kim, G. Lee,
B.-Y. Lee, J. Y. Baek and K. S. Kim, Tetrahedron, 2010, 66, 5687.
14 The ratio of trans,trans/trans,cis-14 was varied between (E)- and
(Z)-13: 2.6/1 for (E)- and 1/1 for (Z)-isomer (see ESIw).
15 P. A. Grieco, S. Gilman and M. Nishizawa, J. Org. Chem., 1976,
41, 1485.
16 W. Yu, Y. Mei, Y. Kang, Z. Hua and Z. Jin, Org. Lett., 2004, 6, 3217.
17 For a direct introduction of thymine base into 17 in an SN2
manner, inversion of configuration of the secondary hydroxyl
was attempted by Mitsunobu conditions or oxidation-reduction
sequence. However, all met failure.
It was found that the 4-exo-trig cyclization reaction of the 3,3-
difluoro-4-pentenyl carbon radical efficiently proceeded to furnish
the novel gem-difluorocyclobutane. The electron withdrawing effect
of the two fluorine atoms adjacent to the radical accepting double
bond accelerated the cyclization reaction. As a synthetic application
of this radical ring closure, the synthesis of difluoromethylene
oxetanocin T 4, a potential anti-viral agent, was achieved.
Anti-viral assay revealed that compound 4 did not show any
activity against HIV-1, VZV and HCMV.
The authors are grateful to Ms Y. Odanaka and S. S.
Matsubayashi (Center for Instrumental Analysis, Showa Univer-
sity) for technical assistance with NMR spectroscopy, MS and
elemental analysis. Financial support from the Japan Society
for the Promotion of Science (KAKENHI No. 21590123 to
K.H.) is gratefully acknowledged.
Notes and references
1 N. Shimada, S. Hasegawa, T. Harada, T. Yomisawa, A. Fujii and
T. Takita, J. Antibiot., 1986, 39, 1623.
2 (a) H. Hoshino, N. Shimizu, N. Shimada, T. Takita and T. Takeuchi,
J. Antibiot., 1987, 40, 1077; (b) N. Shimada, S. Hasegawa, S. Saito,
18 (a) R. Csuk and Y. von Scholz, Tetrahedron, 1995, 51, 7193;
(b) P. Wang, L. A. Agrofoglio, M. G. Newton and C. K. Chu,
J. Org. Chem., 1999, 64, 4173.
c
This journal is The Royal Society of Chemistry 2012
Chem. Commun., 2012, 48, 10993–10995 10995